DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/c9fbq3/organ) has announced the addition of the "Worldwide Organ Preservation Solutions Market 2013 - 2019" report to their offering.
Some of the prominent players in the organ preservation solutions market that have been profiled in this report include Dr. Franz Köhler Chemie GmbH, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, BioLife Solutions, Inc., XVIVO Perfusion AB and ToleroTech, Inc.
This report studies the global organ preservation solutions market based on the various solutions available in the market in which organs are preserved, type of preservation techniques used and the major geographic markets. The global market for organ preservation solutions has been segmented into nine major solutions that include Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and others (Ross-Marshall Citrate Solutions, Celsior Solution, Phosphate-Buffered Sucrose Solution, ET-Kyoto, TranSend, HetaFreeze, MaPersol and CryoStor).
On the basis of preservation techniques, the market has been segmented into three categories namely hypothermic perfusion preservation (HPP), static cold storage (SCS) and others (that include normothermic preservation and oxygen insufflation techniques).
Geographically, the report studies the global market with respect to four main regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecasts in terms of revenue (USD million) for the period 2011 to 2019, considering 2012 as the base year, have been provided for each solution type, technique type and geographic region. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for all the aforementioned segments.
The market overview section of the report discusses the market dynamics that include drivers, restraints and opportunities influencing the market. This section also covers a market attractiveness analysis (by geography) for the year 2012 and Porter's five forces analysis for the global organ preservation solutions market. Market share (%) for the major players operating in this market has also been provided for the year 2012 in the competitive landscape section, followed by a list of recommendations for the existing and new players.
The report also includes company profiles of key players operating in various segments of the market. Each company profile includes the business overview, financial overview, product portfolio, business strategies and recent developments of the respective company.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Market Overview
- Aging global population
- Global rate of aging population
- Technological advancements
- Increasing reimbursement scenario
- Increase in per capita healthcare expenditure
- Lack of organ donors
- Widening Gap Between Patients Receiving Organ Transplants and Number of Donors in the U.S. (1998 - 2010)
- High cost of procedure
- Collaboration with research-oriented organizations and medical institutes to ensure retention of customer base
- Porter's Five Force Analysis for the Global Organ Preservation Solutions Market
Chapter 4 Global Organ Preservation Solutions Market, By Solution, 2011 - 2019 (USD Million)
- Custodiol HTK - (Histidine-Tryptophan-Ketoglutarate) Solution
- Human bioSystem (HBS) Solution
- siRNA Transplant Solution
Chapter 5 Global Organ Preservation Solutions Market, By Preservation Technique, 2011 - 2019 (USD Million)
- Hypothermic Perfusion Preservation (HPP)
- Static Cold Storage (SCS)
Chapter 6 Global Organ Preservation Solutions Market, By Geography, 2011 - 2019 (USD Million)
Chapter 7 Competitive Landscape
Chapter 8 Recommendations
- Long term contracts with healthcare service providers
- Broadening of distribution network
- Product innovation
Chapter 9 Company Profiles
- 21st Century Medicine
- BioLife Solutions, Inc.
- BioTime, Inc.
- Bristol-Myers Squibb
- Claris Lifesciences Limited
- CryoLife, Inc.
- Dr. Franz Köhler Chemie GmbH
- Lifeline Scientific
- Teva Pharmaceutical Industries Ltd.
- ToleroTech, Inc.
- XVIVO Perfusion AB
For more information visit http://www.researchandmarkets.com/research/c9fbq3/organ